Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Myosin Therapeutics Inc.
Myosin Therapeutics Initiates Phase 1/2 STAR-GBM Trial of MT-125 Targeting Non-muscle Myosin II in Newly Diagnosed Glioblastoma
May 19, 2026
Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial
March 24, 2026
Myosin Therapeutics Invited to Present at Two South Florida Life Sciences Conferences
March 9, 2026
Myosin Therapeutics Invited to Present at Biocom California’s Global Partnering & Investor Conference
January 30, 2026